Home Innovation That Matters

Innovation That Matters

Algomedix Hopes New Class of Pain Drugs Will Curb Dangers of Opioids

While the opioid epidemic in the US has become a serious public health issue, research into alternative, non-addictive pain drug research and development in the US pharmaceutical industry has not matched the urgent need. However, innovative and more nimble biotech companies may ultimately come...

The Race is on for Drugs to Treat Aging, but the Outcome is Far From Settled

Targeting aging with therapeutic interventions to slow the inexorable march of biological decline is moving from the fringe of biomedical research to legitimacy, but numerous challenges remain before pharmacies start dispensing prescription medicines for a longer life. For starters, governments do not recognize aging as...

Hydra Biosciences sees TRP Ion Channels as Pathway to Opioid Alternatives

While sky-rocketing death tolls from opioid pain drug addiction in the US have dominated the headlines in recent years, only slim effort has been made to find the alternative, non-habit-forming pain-killers doctors need to treat chronic pain. In fact, only a relative handful of...

‘Shared’ Pathways to Success: Viela Bio’s Quest to Develop First-in-Class Molecules to Treat High Unmet Medical Needs

By Rich Soll, Senior Advisor, Strategic Initiatives at WuXi AppTec (@richsollwx) Viela Bio, a new spin-out from biotech trailblazer MedImmune, expects to bring new hope to patients who suffer from autoimmune and inflammatory diseases via its robust pipeline of unique molecules.  Armed with a recent...

Deep Impact: How Passion, Dedication & Good Science Revived a Life-Saving Drug

By Rich Soll, Senior Advisor, Strategic Initiatives at WuXi AppTec (@richsollwx) This is the story of a scientist whose quick rise to successful entrepreneur was driven by the sheer dedication and passion to revive a shelved drug of profound effect that saves patients’ lives. Meet John...

SPOTLIGHT

STAY CONNECTED

Twitter LinkedIn 

WUXI NEWS

WuXi AppTec Expands Site in the United States for Drug Development...

We are pleased to announce the grand opening of WuXi AppTec's expanded Laboratory Testing Division (LTD) facility in New Jersey. The expansion will double total...